The IDI
The IDI
Valuate Health Consultancy
Why Prior Authorization Matters for Pharma
30 minutes Posted Oct 2, 2023 at 4:00 am.
0:00
30:37
Download MP3
Show notes

It’s hard to think of an aspect of health care more vexing than prior authorizations. In fact, prior authorizations are so frustrating that Congress is looking into a legislative solution. 

This episode of The IDI we have two guests to explain the state of prior authorization and how to improve the process. 

John Hennessy is a principal with Valuate Health with a background in oncology and cancer care.

Syam Palakurthy is co-founder and CEO of SamaCare, a company that streamlines the prior authorization process for medical benefit drugs. 

Follow Valuate on LinkedIn